Cynthia Dorothy Perettie has officially filed a Form 3 with the Securities and Exchange Commission (SEC), disclosing her ownership status and role as a director at Aspen Neuroscience, Inc. This filing is significant as it underscores the transparency and governance practices within the biotech sector, particularly in the pharmaceutical preparations industry.

Background

Aspen Neuroscience, Inc. is a company incorporated in Delaware, primarily engaged in the pharmaceutical preparations sector, as indicated by its Standard Industrial Classification (SIC) code 2834. The company operates out of San Diego, California, at the address 10835 Road to the Cure, Suite 100. The company is identified by its Central Index Key (CIK) number 0002124080. Recent filings include the Form 3 submitted on October 29, 2026.

What the Filing Says

The filing details that Perettie holds one security in Aspen Neuroscience and confirms her position as a director. The document states, "The undersigned hereby makes, constitutes and appoints..." which reflects her authority and responsibilities within the company.

Impact

This filing may affect various stakeholders, including shareholders and potential investors, as it provides insight into the governance structure of Aspen Neuroscience. Perettie's role as a director indicates her influence in decision-making processes at the company.

What's Next

The filing does not say what happens next.